文献速递妇产影像儿科影像神经USMR

先天性巨细胞病毒感染且诊断时超声正常的胎儿结局:系统综述与荟萃分析

Outcome of fetuses with congenital cytomegalovirus infection and normal ultrasound at diagnosis: systematic review and meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-03-09

该系统综述与荟萃分析纳入26项研究、2603例先天性巨细胞病毒感染胎儿,其中1178例(45.3%)诊断时超声正常。随访超声新发现中枢神经系统异常率4.4%,仅产前MRI发现者占5.8%;无异常者出生后症状性感染1.5%、神经发育异常3.1%、听力问题6.5%。

要点

  • 诊断时超声正常的先天性巨细胞病毒感染胎儿,随访超声新发现中枢神经系统异常率为4.4%。
  • 仅产前MRI发现而超声漏诊的中枢神经系统异常率为5.8%,提示MRI有附加价值。
  • 无产前或产后异常者中,听力问题发生率6.5%,高于神经发育异常3.1%。

诊断标准与关键数值

  • 随访超声新发现中枢神经系统异常率4.4%(95%CI 1.4-8.8%)(32/523;15项研究)。
  • 仅产前MRI发现而超声漏诊的中枢神经系统异常率5.8%(95%CI 1.9-11.5%)(19/357;11项研究)。
  • 出生后影像发现而产前漏诊的中枢神经系统异常率3.2%(95%CI 0.3-9.0%)(50/660;17项研究)。
  • 随访超声新发现中枢神经系统外异常率2.9%(95%CI 0.8-6.3%)(19/523;15项研究)。
  • 仅MRI发现的中枢神经系统外异常率0%(95%CI 0.0-1.7%)(0/357;11项研究);出生后影像发现而产前漏诊者0.9%(95%CI 0.3-1.8%)(4/660;17项研究)。

临床应用与阅片要点

  • 无产前或产后异常者中,症状性感染率1.5%(95%CI 0.7-2.7%)(6/548;19项研究)。
  • 无产前或产后异常者中,神经发育异常率3.1%(95%CI 1.6-5.1%)(16/550;19项研究)。
  • 无产前或产后异常者中,听力问题发生率6.5%(95%CI 3.8-10.0%)(36/550;19项研究)。
  • 宫内死亡和围产期死亡各为0.7%(95%CI 0.3-1.4%)(2/824;23项研究)。
  • 与第二或第三孕期感染相比,第一孕期感染的胎儿随访超声或MRI发现额外异常、神经发育异常及听力问题的风险相对较高。

局限性

  • 按母亲感染孕期的亚组分析受纳入病例数很少及原始研究未比较所观察结局的限制。
  • 第一孕期感染与第二或第三孕期感染的比较基于相对较高的风险描述,受上述限制影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To report the outcome of fetuses with congenital cytomegalovirus (CMV) infection and normal ultrasound at the time of diagnosis, and to evaluate the rate of an additional anomaly detected only on magnetic resonance imaging (MRI).

METHODS: Medline, EMBASE, CINAHL and Cochrane databases were searched for studies reporting on the outcome of fetuses with congenital CMV infection. Inclusion criteria were fetuses with confirmed CMV infection and normal ultrasound assessment at the time of the initial evaluation. The outcomes observed were an anomaly detected on a follow-up ultrasound scan, an anomaly detected on prenatal MRI but missed on ultrasound, an anomaly detected on postnatal assessment but missed prenatally, perinatal mortality, symptomatic infection at birth, neurodevelopmental outcome and hearing and visual deficits. Neurodevelopmental outcome was assessed only in cases of isolated CMV infection confirmed at birth. Subgroup analysis was performed according to the trimester in which maternal infection occurred. Random-effects meta-analysis of proportions was used to analyze the data.

RESULTS: Twenty-six studies were included, comprising 2603 fetuses with congenital CMV infection, of which 1178 (45.3%) had normal ultrasound at the time of diagnosis and were included in the analysis. The overall rate of an associated central nervous system (CNS) anomaly detected on a follow-up ultrasound scan was 4.4% (95% CI, 1.4-8.8%) (32/523; 15 studies), while the rates of those detected exclusively on prenatal MRI or on postnatal imaging were 5.8% (95% CI, 1.9-11.5%) (19/357; 11 studies) and 3.2% (95% CI, 0.3-9.0%) (50/660; 17 studies), respectively. The rate of an associated extra-CNS anomaly detected on a follow-up ultrasound scan was 2.9% (95% CI, 0.8-6.3%) (19/523; 15 studies), while the rates of those detected exclusively on MRI or on postnatal imaging were 0% (95% CI, 0.0-1.7%) (0/357; 11 studies) and 0.9% (95% CI, 0.3-1.8%) (4/660; 17 studies), respectively. Intrauterine death and perinatal death each occurred in 0.7% (95% CI, 0.3-1.4%) (2/824; 23 studies) of cases. In cases without an associated anomaly detected pre- or postnatally, symptomatic infection was found in 1.5% (95% CI, 0.7-2.7%) (6/548; 19 studies) of infants, the overall rate of a neurodevelopmental anomaly was 3.1% (95% CI, 1.6-5.1%) (16/550; 19 studies), and hearing problems affected 6.5% (95% CI, 3.8-10.0%) (36/550; 19 studies) of children. Subanalyses according to the trimester in which maternal infection occurred were affected by the very small number of included cases and lack of comparison of the observed outcomes in the original studies. Compared with fetuses infected in the second or third trimester, those infected in the first trimester had a relatively higher risk of having an additional anomaly detected on follow-up ultrasound or MRI, abnormal neurodevelopmental outcome and hearing problems.

CONCLUSIONS: In fetuses with congenital CMV infection in which no anomalies are detected on prenatal ultrasound or MRI, the risk of adverse postnatal outcome is lower than that reported previously in the published literature when not considering the role of antenatal imaging assessment. The results from this review also highlight the potential role of MRI, even in fetuses with no anomalies detected on ultrasound, as an anomaly can be detected exclusively on MRI in about 6% of cases. The findings from this study could enhance prenatal counseling of pregnancies with congenital CMV infection with normal prenatal imaging. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Buca D, Di Mascio D, Rizzo G, et al. Outcome of fetuses with congenital cytomegalovirus infection and normal ultrasound at diagnosis: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2021. PMID: 33030767. doi:10.1002/uog.23143

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。